Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,553.78
(
-0.41%
)
US TECH 100
23,350.40
(
-0.72%
)
Dow Jones
46,092.58
(
-0.25%
)
Brent Oil
100.16
(
3.48%
)
Bitcoin
70,060.00
(
-1.18%
)
News Focus
News Focus
Post# of 257275
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

genisi

Send PM Follow Ignore
Followers 28
Posts 5148
Boards Moderated 0
Alias Born 05/24/2006

genisi

Re: DewDiligence post# 140466

Friday, 04/20/2012 8:26:55 AM

Friday, April 20, 2012 8:26:55 AM

Post# of 257275

GILD appears to be keeping the phase-2 data on GS-5885 (the NS5A inhibitor) under wraps

I think that GILD already has a data from several hundreds patients who have been on GS-5885 in one of those regimens, for 12 or 24 weeks. There should be a poster(s).
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today